Lv1
38 积分 2025-02-11 加入
STRIvE-02: A First-in-Human Phase I Study of Systemically Administered B7-H3 Chimeric Antigen Receptor T Cells for Patients With Relapsed/Refractory Solid Tumors
9小时前
待确认
Dual-target CAR-T therapy for ovarian cancer: synergistic targeting of MSLN and B7H3 enhances anti-tumor efficacy and overcomes antigen heterogeneity
7天前
已完结
SLAMF6 Restrains T-Cell Function and Limits Antitumor Immunity
14天前
已关闭
A logic-gated trispecific engager enhances macrophage killing of cancer cells in solid tumors
1个月前
已完结
Rheumatoid Arthritis — Common Origins, Divergent Mechanisms
3个月前
已完结
Engineering circular RNA medicines
4个月前
已完结
Protection of Transplanted Hematopoietic Stem Cells from Inflammatory Recipient Marrow Environment through Specific TNF-α Signal Blockade
8个月前
已完结
皖公网安备34019202002308
